In a clinical trial, Mark Rubinstein, Ph.D., (left) and John Wrangle, M.D., used two drugs that have never been combined in humans before to slow the progression of lung cancer.
Nancy DeMore, M.D. is leading a clinical trial using frankincense to try to treat breast and colon cancer at the Medical University of South Carolina. The study was inspired by a research specialist in DeMore’s lab.
Nancy DeMore, M.D. teamed up with Clemson engineering students to work on a device that will improve patient experience and lower costs.